Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
POLEP: Itanapraced in Mild Cognitive Impairment
NCT01602393Phase 2Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- May 2012
- Primary completion
- Oct 2013
- Countries
- 2
01
Overview
A Phase 2 trial of Itanapraced in Mild Cognitive Impairment (MCI), sponsored by Chiesi Farmaceutici S.p.A.. Started May 2012; status: completed.
02
Drugs
Itanapraced
03
Conditions
Mild Cognitive Impairment (MCI)
Beyond the preview
Go deeper on NCT01602393.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01602393.